Yungjin Pharmaceutical Co., Ltd. (003520) - Financials, balance sheet (quarterly)

2,170 KRW

3.77%

Last update May 19, 3:00 PM KST

Market closed

Day range

2,170

2,155

2,245

Previous close

2,255

Open

2,240

Access this stock data via API

Yungjin Pharmaceutical Co., Ltd.

2,170.00

3.77%

Financials

Balance sheet

Fiscal date	Dec 2024	Sep 2024	Jun 2024	Mar 2024
Total assets	234.3B	236.2B	235.7B	233.8B
Current assets	123.8B	129.9B	134.3B	134.0B
Cash	3.4B	5.5B	10.1B	10.6B
Cash equivalents	—	—	—	—
Cash and cash equivalents	3.4B	5.5B	10.1B	10.6B
Other short term investments	—	10B	5B	5B
Accounts receivable	46.0B	43.9B	49.5B	50.3B
Other receivables	3.2B	2.3B	2.3B	2.2B
Inventory	70.9B	67.3B	66.1B	64.2B
Prepaid assets	255.7M	752.7M	1.3B	1.7B
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	20	—	—	—
Non current assets	110.4B	106.3B	101.3B	99.8B
Properties	14.6B	93.8B	88.6B	86.3B
Land and improvements	20.1B	—	—	—
Machinery furniture equipment	95.2B	—	—	—
Construction in progress	20.8B	—	—	—
Leases	—	—	—	—
Accumulated depreciation	-87.4B	—	—	—
Goodwill	1.7B	1.7B	1.9B	2.2B
Investment properties	1.1B	1.1B	1.1B	1.1B
Financial assets	—	—	—	—
Intangible assets	1.7B	1.7B	1.9B	2.2B
Investments and advances	—	—	—	—
Other non current assets	20	-20	—	—
Total liabilities	144.5B	144.2B	143.3B	140.1B
Current liabilities	114.6B	88.6B	89.2B	88.0B
Accounts payable	22.8B	23.3B	23.1B	23.6B
Accrued expenses	—	—	—	—
Short term debt	60.5B	34.5B	36.0B	36.0B
Deferred revenue	—	—	—	—
Tax payable	308.7M	267.2M	212.1M	138.9M
Pensions	—	—	—	—
Other current liabilities	1.3B	1.3B	1.3B	1.6B
Non current liabilities	29.8B	55.6B	54.1B	52.0B
Long term provisions	—	—	—	—
Long term debt	4.6B	31.0B	30.0B	30.4B
Provision for risks and charges	380	390	450	140.0M
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	3.7B	3.5B	3.5B	1.8B
Shareholders equity
Common stock	91.4B	91.4B	91.4B	91.4B
Retained earnings	-17.6B	-15.5B	-15.1B	-13.7B
Other shareholders equity	—	—	—	—
Total shareholders equity	89.8B	92.0B	92.3B	93.7B
Additional paid in capital	16.0B	16.0B	16.0B	16.0B
Treasury stock	—	—	—	—
Minority interest	—	—	—	—